Cargando…
Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies
BACKGROUND: The advent of personalized medicine requires robust, reproducible biomarkers that indicate which treatment will maximize therapeutic benefit while minimizing side effects and costs. Numerous molecular signatures have been developed over the past decade to fill this need, but their valida...
Autores principales: | Starmans, Maud HW, Pintilie, Melania, John, Thomas, Der, Sandy D, Shepherd, Frances A, Jurisica, Igor, Lambin, Philippe, Tsao, Ming-Sound, Boutros, Paul C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580418/ https://www.ncbi.nlm.nih.gov/pubmed/23146350 http://dx.doi.org/10.1186/gm385 |
Ejemplares similares
-
Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences
por: Fox, Natalie S, et al.
Publicado: (2014) -
Optimized application of penalized regression methods to diverse genomic data
por: Waldron, Levi, et al.
Publicado: (2011) -
Biomarkers and subtypes of cancer
por: Starmans, Maud H.W., et al.
Publicado: (2015) -
Optimizing Drug Response Study Design in Patient-Derived Tumor
Xenografts
por: Weiss, Jessica, et al.
Publicado: (2022) -
Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC)
por: Dhont, Ludovic, et al.
Publicado: (2018)